Filter
5628
Filtered Results: 5628
Text search:
drug
import
Featured
Recommendations
492
New Publications
1493
Language
Document type
No document type
3487
Studies & Reports
821
Guidelines
711
Manuals
240
Strategic & Response Plan
152
Fact sheets
80
Training Material
74
Situation Updates
19
Infographics
16
Brochures
14
Resource Platforms
10
Online Courses
2
App
1
Videos
1
Countries / Regions
India
355
Kenya
175
Global
170
South Africa
139
Ethiopia
126
Uganda
120
Western and Central Europe
117
Nigeria
112
Tanzania
99
Nepal
91
Sierra Leone
90
Liberia
90
Malawi
84
Zambia
82
Myanmar / Burma
79
Africa
77
Ghana
74
Bangladesh
72
Latin America and the Carribbean
69
Rwanda
66
Eastern Europe
52
Ukraine
50
Namibia
49
Philippines
46
Zimbabwe
45
South–East Asia Region
39
Cambodia
38
Asia
37
Lesotho
35
Congo, Democratic Republic of
32
Senegal
27
Russia
27
Botswana
27
Syria
25
Mozambique
25
Indonesia
25
Colombia
23
Burkina Faso
22
Eswatini/ Swaziland
22
Germany
19
East and Southern Africa
18
Brazil
18
South Sudan
18
West and Central Africa
17
Middle East and North Africa
17
Haiti
16
Cameroon
15
Venezuela
15
USA
13
Eastern Europe and Central Asia
13
Tajikistan
12
Argentina
12
Pakistan
12
Guinea
11
Thailand
10
Benin
10
Albania
10
Peru
10
Paraguay
10
Georgia
10
Vietnam
9
China
8
Chile
8
Afghanistan
8
Sudan
8
Laos
7
Bolivia
7
Moldova
7
North Macedonia
6
Mexico
6
El Salvador
6
Armenia
6
Western Pacific Region
6
Yemen
6
Lebanon
5
Sri Lanka
5
Central African Republic
5
Mali
5
Iraq
5
Jordan
4
Jamaica
4
United Kingdom
4
Papua New Guinea
4
Libya
4
Somalia
4
Timor Leste/ East Timor
3
Iran
3
Kyrgyzstan
3
Morocco
3
North America
3
Spain
3
Southern Africa
3
Palestine
3
Angola
3
Bhutan
3
Ecuador
3
Madagascar
3
Serbia
2
Turkey
2
Kazakhstan
2
Canada
2
Fiji
2
Mongolia
2
Guinea-Bissau
2
Hungary
2
Saudi Arabia
2
Gabon
2
Uruguay
2
Belgium
2
France
2
Portugal
2
Belarus
2
Côte d’Ivoire / Ivory Coast
2
Poland
2
Honduras
2
North Korea
1
Switzerland
1
Gambia
1
Singapore
1
Estonia
1
Congo-Brazzaville
1
Niger
1
Malaysia
1
Qatar
1
Bulgaria
1
Italy
1
Lithuania
1
Ireland
1
Turkmenistan
1
Denmark
1
Maldives
1
Mauritius
1
Tunisia
1
Norway
1
Nicaragua
1
Egypt
1
Romania
1
Greece
1
Chad
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
2164
Clinical Guidelines
532
Public Health
270
Women & Child Health
227
Key Resources
108
Capacity Building
88
Pharmacy & Technologies
67
Annual Report MEDBOX
1
Toolboxes
HIV
659
Mental Health
581
TB
545
AMR
295
COVID-19
235
Pharmacy
176
NTDs
173
NCDs
120
Caregiver
115
Rapid Response
92
Ebola
82
Refugee
77
Planetary Health
77
Disability
67
Conflict
60
Global Health Education
54
Health Financing Toolbox
36
Polio
22
Natural Hazards
21
Specific Hazards
18
Cholera
18
Social Ethics
17
Zika
16
Health Financing
1
https://doi.org/10.1371/journal.pntd.0002439
South Sudan has a high burden – among the highest in sub-Saharan Africa – of neglected tropical diseases (NTDs). This adversely affects the health and social and economic well-being of people in the country. The prevention, control and eventual elim...
The report aims to capture lessons from the COVID-19 pandemic and to highlight the opportunity for more ambitious global action: expanding sustainable access to vaccines for all towards the Immunization Agenda 2030 and pandemic prevention, preparedness and response efforts. The report is organized i...
UNFPA has been implementing programming for women and girls through Women Friendly Health Spaces (WFHSs), which provide access to critical services, information and support. The WFHS is providing: psychosocial counseling services; awareness raising sessions on PSS in the community; and life skills &...
The Country Cooperation Strategy is the World Health Organization’s corporate framework developed in response to a country’s needs and priorities. The 2022–2025 CCS is the fourth for WHO in Sierra Leone. It is a medium-term strategic document that defines a broad framework for WHO’s work, at...
Adolescence, defined as the period between 10 and 19 years of age, is a developmental stage during which many psychosocial and mental health challenges emerge. There is a well-established link between mental health and HIV outcomes. Adolescents and young adults living with HIV typically have additio...
This publication describes the first WHO public-benefit Target Product Profiles (TPPs) for snakebite antivenoms. It focuses on antivenoms for treatment of snakebite envenoming in sub-Saharan Africa. Four TPPs are described in the document:
Broad spectrum Pan-African polyvalent antivenoms: products ...
The Quadripartite organizations have developed the One Health Priority Research Agenda for AMR report, this is a joint initiative to assist in directing and catalysing scientific interest and financial investments for the priority research agenda across sectors for countries and funding bodies. The ...
This report presents findings from research conducted by Economist Impact to assess the health, demographic, social and economic impacts associated with different scenarios for financing the HIV epidemic across 13 selected countries in Sub-Saharan Africa. The sponsorship of UNAIDS towards this repor...
This policy brief describes key HIV viral load thresholds and the available viral load testing approaches for monitoring how well antiretroviral therapy is working for people living with HIV. It provides clarification for and elaborates upon the current treatment monitoring algorithm from the Consol...
This document provides technical guidance on concepts, definitions, indicators, criteria, milestones and tools to assist leprosy programmes in their journey towards the goals of interruption of transmission and elimination of leprosy disease and through the post-elimination period. Importantly, it p...
The world has been turned on its head by the coronavirus disease 2019 (COVID-19) pandemic. This has provided a stark wakeup call on the severe under-financing of health systems around the world. It has laid bare the inequalities and limitations in the capacities of countries at all levels of develop...
The Creditor Reporting System was analysed for official development assistance funding disbursements towards TB control in 11 conflict-affectedstates, 17 non-conflict-affected fragile states and 38 comparable non-fragile states. The amounts of funding, funding relative to burden, funding relative to...
There has been no systematic comparison of how the policy response to past infectious disease outbreaks and epidemics was funded. This study aims to collate and analyse funding for the Ebola epidemic and Zika outbreak between 2014 and 2019 in order to understand the shortcomings in funding reporting...
Development finance institutions owned by European governments and the World Bank Group are spending hundreds of millions of dollars on expensive for-profit hospitals in the Global South that block patients from getting care, or bankrupt them, with some even imprisoning patients who cannot afford th...
The GFF needs an additional US$2.5 billion from 2021 to 2025 to enable countries to protect health gains and accelerate progress toward the 2030 Goals. Of this amount, the GFF urgently needs to secure new pledges of US$1.2 billion by the end of 2021 to help its current 36 partner countries protect ...
This report examines the support to private healthcare provision in India by the World Bank’s private sector arm, the International Finance Corporation (IFC). Despite supporting private healthcare in the country since 1997, no healthcare results for lending and investments have been disclosed sinc...
Over the 20 years that followed, this unique partnership has invested more than US$53 billion, saving 44 million lives and reducing the combined death rate from the three diseases by more than half in the countries in which the Global Fund invests.
This report makes clear that there is a path to end AIDS. Taking that path will help ensure preparedness to address other pandemic challenges, and advance progress across the Sustainable Development Goals. The data and real-world examples in the report make it very clear what that path is. It is not...
The waves of yellow fever transmission in the Region of the Americas in 2016–2018 involved the largest number of human and epizootic cases to be reported in several decades. Yellow fever is a serious viral hemorrhagic disease that poses a challenge for health professionals. It requires early recog...
Las olas de transmisión de la fiebre amarilla ocurridas en la Región de las Américas entre el 2016 y el 2018 causaron el mayor número de casos humanos y epizoóticos registrados en varios decenios. La fiebre amarilla es una enfermedad hemorrágica viral grave que representa un desafío para el p...
